featured
Daratumumab Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Daratumumab Plus Pomalidomide and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
Blood 2017 Jun 21;[EPub Ahead of Print], A Chari, A Suvannasankha, JW Fay, B Arnulf, JL Kaufman, JJ Ifthikharuddin, BM Weiss, A Krishnan, S Lentzsch, R Comenzo, J Wang, K Nottage, C Chiu, NZ Khokhar, T Ahmadi, S LonialFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.